PURPOSE: The purpose of this study was to identify the molecular basis of albinism in a large cohort of Italian patients showing typical ocular landmarks of the disease and to provide a full characterization of the clinical ophthalmic manifestations. METHODS: DNA samples from 45 patients with ocular manifestations of albinism were analyzed by direct sequencing analysis of five genes responsible for albinism: TYR, P, TYRP1, SLC45A2 (MATP), and OA1. All patients studied showed a variable degree of skin and hair hypopigmentation. Eighteen patients with distinct mutations in each gene associated with OCA were evaluated by detailed ophthalmic analysis, optical coherence tomography (OCT), and fundus autofluorescence. RESULTS: Disease-c...
PURPOSE: Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by ...
AIM: Oculocutaneous albinism type 1 (OCA1) is due to TYR mutations. c.1205G>A/p.Arg402Gln (R402Q) is...
Background Oculocutaneous albinism (OCA) refers to a group of inherited disorders where the patient...
PURPOSE: The purpose of this study was to identify the molecular basis of albinism in a large coh...
PURPOSE: The purpose of this study was to identify the molecular basis of albinism in a large cohor...
PURPOSE. The purpose of this study was to identify the molecular basis of albinism in a large cohort...
Abstract We studied the scientific literature and disease guidelines in order to sum...
Purpose : Oculocutaneous albinism type 1 (OCA1) is the most common cause of albinism in European pop...
Albinism is a heterogeneous group of genetic disorders resulting from deficiencies in pigmentation. ...
Oculocutaneous albinism (OCA) is a genetically heterogeneous group of disorders characterized by abs...
Oculocutaneous albinism (OCA) and ocular albinism (OA) are inherited disorders of melanin biosynthes...
Background: Oculocutaneous albinism (OCA) is caused by a group of genetically heterogeneous inherite...
Purpose: Albinism is a rare genetic disorder of melanin production, which can affect only eyes or si...
Purpose: To elucidate the molecular genetics defect of ocular cutaneous albinism. Methods: One memb...
BACKGROUND: Oculocutaneous albinism (OCA) is a clinically and genetically heterogenic group of pigme...
PURPOSE: Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by ...
AIM: Oculocutaneous albinism type 1 (OCA1) is due to TYR mutations. c.1205G>A/p.Arg402Gln (R402Q) is...
Background Oculocutaneous albinism (OCA) refers to a group of inherited disorders where the patient...
PURPOSE: The purpose of this study was to identify the molecular basis of albinism in a large coh...
PURPOSE: The purpose of this study was to identify the molecular basis of albinism in a large cohor...
PURPOSE. The purpose of this study was to identify the molecular basis of albinism in a large cohort...
Abstract We studied the scientific literature and disease guidelines in order to sum...
Purpose : Oculocutaneous albinism type 1 (OCA1) is the most common cause of albinism in European pop...
Albinism is a heterogeneous group of genetic disorders resulting from deficiencies in pigmentation. ...
Oculocutaneous albinism (OCA) is a genetically heterogeneous group of disorders characterized by abs...
Oculocutaneous albinism (OCA) and ocular albinism (OA) are inherited disorders of melanin biosynthes...
Background: Oculocutaneous albinism (OCA) is caused by a group of genetically heterogeneous inherite...
Purpose: Albinism is a rare genetic disorder of melanin production, which can affect only eyes or si...
Purpose: To elucidate the molecular genetics defect of ocular cutaneous albinism. Methods: One memb...
BACKGROUND: Oculocutaneous albinism (OCA) is a clinically and genetically heterogenic group of pigme...
PURPOSE: Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by ...
AIM: Oculocutaneous albinism type 1 (OCA1) is due to TYR mutations. c.1205G>A/p.Arg402Gln (R402Q) is...
Background Oculocutaneous albinism (OCA) refers to a group of inherited disorders where the patient...